Search

Search Constraints

You searched for: Author/Creator Prat, Alexandre

Search Results

2. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier. Issue 8 (August 2017)

3. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. (5th September 2017)

5. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. (14th June 2022)

6. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. (October 2018)

7. CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis. Issue 6 (9th November 2022)

8. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

9. Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Issue 2 (April 2016)

10. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Issue 12 (19th October 2022)